SecBot SecBot

ENZN

Viskase Holdings, Inc.
OTC· Biological Products, (No Diagnostic Substances)· Inc. DE· CIK 0000727510 Biotech & Drug Discovery
—
Next earnings
Nov 10
in 14 days
Short interest
1.2K
+57950.0%
Days to cover
1.0
at average volume
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 10, 2026
Strongest NEUTRAL Enzon Pharmaceuticals extended the expiration date of its Section 382 Rights Agreement from noon, New York…
All reports →

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • Short sellersBUILDING

    Short interest +57950.0% to 1.2K shares. 1.0 days to cover.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 12, 2026 Earnings calendar
ENZN Q2 2026 Earnings Scheduled — 2026-08-12
Mar 18, 2026 SEC
Enzon Pharmaceuticals extended the expiration date of its Section 382 Rights Agreement from noon, New York City time…
8-K — Impact 3/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 10, 2026
Earnings date
ENZN Q3 2026 Earnings Scheduled — 2026-11-10
Recent
Aug 12, 2026
Earnings date
ENZN Q2 2026 Earnings Scheduled — 2026-08-12
May 7, 2026
Earnings date
ENZN Q1 2026 Earnings Scheduled — 2026-05-07

Earnings setup

Estimates
Nov 10
reports in 14 days
PeriodEPS est.Range30D rev.Revenue
Current FY———$0.00
Current Q———$0.00
Next Q———$0.00
Next FY———$0.00

Short side

FINRA· Jul 15, 2026
1,161
shares short
+57950.0%
vs prior settlement
1.0
days to cover

SecBot reports

1 filing · 0 bullish · 0 bearish · 1 neutral
All ENZN filing & press-release reports (1)